For 13 years, a small medical device company named Lexion Medical has relied on Dallas attorney David Wille to protect its intellectual property rights. And after building a case that a competitor’s false statements caused Lexion’s sales to tank, Wille persuaded a Delaware jury to award $12.2 million in damages in favor of his client.
Lexion sold a device that delivers heat and humidified carbon dioxide into the abdomen, causing it to expand during laparoscopic surgery, which offers increased health and safety benefits, Lexion has said. Lexion’s competitor, SurgiQuest, sold another device, called the AirSeal system, which uses different technology to serve the same function during laparoscopic surgery.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
